Ultralife Upgraded to Neutral on Backlog & Product Commercialization
Ultralife Stock Gains Post Q2 Earnings Despite Y/Y Revenue Dip
CORRECTION: Ultralife Q2 EPS $0.15 Up From $0.05 YoY, Sales $47.943M Down From $48.561M YoY
Ultralife (ULBI) Q2 2026 Earnings Call Transcript
Ultralife Q2 Earnings Call Highlights
Ultralife Corp (ULBI) (Q2 2026) Earnings Call Highlights: Record Backlog and Margin Expansion ...
Ultralife Corporation (ULBI) Q2 2026 Earnings Call Transcript
Ultralife Corporation Reports Second Quarter Results
Ultralife Corporation to Report Second Quarter Results on August 7, 2026
Zacks Initiates Coverage of Ultralife With Underperform Recommendation
Ultralife (ULBI) Q1 2026 Earnings Transcript
Ultralife Corp (ULBI) Q1 2026 Earnings Call Highlights: Record Backlog Amid Revenue Challenges
Ultralife Q1 Earnings Call Highlights
Ultralife Corporation (ULBI) Q1 2026 Earnings Call Transcript
Ultralife Corporation (NASDAQ:ULBI) Plunges 8% on Q1 2026 Revenue and Earnings Miss
Ultralife Corporation Reports First Quarter Results
Ultralife Q1 EPS $(0.03) Misses $0.15 Estimate, Sales $47.445M Miss $52.400M Estimate
Ultralife Corporation to Report First Quarter Results on May 8, 2026
Ultralife Stock Rallies After Massive Performance Score Spike Signals Bullish Momentum
Ultralife Corp (ULBI) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Challenges
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.